EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+8.07%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.02B
AUM Growth
+$936M
(+23%)
Cap. Flow
+$612M
Cap. Flow
% of AUM
12.18%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
952
New
33
Increased
218
Reduced
88
Closed
22
Top Buys
| 1 |
Apple
AAPL
|
$28.2M |
| 2 |
Shoals Technologies Group
SHLS
|
$23.6M |
| 3 |
Microsoft
MSFT
|
$22.8M |
| 4 |
PayPal
PYPL
|
$22.6M |
| 5 |
Sunrun
RUN
|
$18.1M |
Top Sells
| 1 |
Fiserv
FI
|
$7.72M |
| 2 |
Signet Jewelers
SIG
|
$6.46M |
| 3 |
ServiceNow
NOW
|
$4.96M |
| 4 |
Clean Harbors
CLH
|
$4.47M |
| 5 |
Deere & Co
DE
|
$3.81M |
Sector Composition
| 1 | Technology | 29.94% |
| 2 | Healthcare | 18.79% |
| 3 | Consumer Discretionary | 14.76% |
| 4 | Industrials | 9.14% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Exelixis
EXEL
$10.2B
| $1.63M | 0.03% |
91,000
| – | – |
|
302
Huntington Bancshares
HBAN
$25.7B
| $1.63M | 0.03% |
114,300
+102,300
| +853% | +$1.46M |
|
303
Mercado Libre
MELI
$123B
| $1.58M | 0.03% |
+1,000
| New | +$1.58M |
|
304
Hershey
HSY
$37.6B
| $1.58M | 0.03% |
9,039
+109
| +1% | +$19K |
|
305
Becton Dickinson
BDX
$55.1B
| $1.56M | 0.03% |
6,488
-1,047
| -14% | -$252K |
|
306
Vir Biotechnology
VIR
$732M
| $1.55M | 0.03% |
33,300
| – | – |
|
307
MetLife
MET
$52.9B
| $1.53M | 0.03% |
25,800
+2,100
| +9% | +$125K |
|
308
Fate Therapeutics
FATE
$116M
| $1.53M | 0.03% |
17,200
| – | – |
|
309
Bilibili
BILI
$9.25B
| $1.51M | 0.03% |
+12,000
| New | +$1.51M |
|
310
Adaptive Biotechnologies
ADPT
$1.96B
| $1.51M | 0.03% |
35,700
| – | – |
|
311
American Express
AXP
$227B
| $1.5M | 0.03% |
9,108
+4,008
| +79% | +$658K |
|
312
Baidu
BIDU
$35.1B
| $1.49M | 0.03% |
7,200
| – | – |
|
313
Intellia Therapeutics
NTLA
$1.29B
| $1.49M | 0.03% |
9,800
| – | – |
|
314
Tencent Music
TME
$37.7B
| $1.43M | 0.03% |
+90,000
| New | +$1.43M |
|
315
Enbridge
ENB
$105B
| $1.42M | 0.03% |
35,700
+16,450
| +85% | +$656K |
|
316
DocuSign
DOCU
$16.1B
| $1.42M | 0.03% |
5,000
| – | – |
|
|
TPTX
317
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.42M | 0.03% |
18,700
| – | – |
|
318
Insmed
INSM
$30.7B
| $1.4M | 0.03% |
47,600
| – | – |
|
319
Tesla
TSLA
$1.13T
| $1.33M | 0.03% |
5,844
+4,140
| +243% | +$939K |
|
320
Amicus Therapeutics
FOLD
$2.46B
| $1.31M | 0.03% |
132,000
| – | – |
|
321
Aflac
AFL
$57.2B
| $1.31M | 0.03% |
24,500
+1,600
| +7% | +$85.7K |
|
322
Tenaris
TS
$18.2B
| $1.3M | 0.03% |
60,000
| – | – |
|
323
Berkshire Hathaway Class A
BRK.A
$1.08T
| $1.26M | 0.03% |
+3
| New | +$1.26M |
|
324
Kura Oncology
KURA
$713M
| $1.25M | 0.02% |
58,000
| – | – |
|
325
Kodiak Sciences
KOD
$556M
| $1.25M | 0.02% |
13,700
| – | – |
|